Amendment: SEC Form SC 13G/A filed by Shattuck Labs Inc.

Amendment: SEC Form SC 13G/A filed by Shattuck Labs Inc.

Recent Analyst Ratings for $STTK

$STTK Large Ownership Changes

$STTK Analyst Ratings

$STTK Insider Trading

$STTK Press Releases

$STTK Leadership Updates

$STTK Financials

$STTK Insider Purchases

$STTK SEC Filings

Recent Analyst Ratings for
$STTK

$STTK
Large Ownership Changes

$STTK
Analyst Ratings

$STTK
Insider Trading

$STTK
Press Releases

$STTK
Leadership Updates

$STTK
Financials

$STTK
Insider Purchases

$STTK
SEC Filings

Chat with this insight

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13D/A filed by Shattuck Labs Inc.

Amendment: SEC Form SC 13G/A filed by Shattuck Labs Inc.

Amendment: SEC Form SC 13G/A filed by Shattuck Labs Inc.

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Leerink Partners initiated coverage on Shattuck Labs with a new price target

Shattuck Labs downgraded by Citigroup with a new price target

Shattuck Labs downgraded by Needham

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Technical Officer Shukla Abhinav A. covered exercise/tax liability with 2,261 shares, decreasing direct ownership by 3% to 73,536 units (SEC Form 4)

Chief Business Officer Deyoung Casi covered exercise/tax liability with 2,297 shares, decreasing direct ownership by 3% to 81,465 units (SEC Form 4)

Chief Medical Officer Pandite Arundathy N. covered exercise/tax liability with 3,211 shares, decreasing direct ownership by 2% to 206,265 units (SEC Form 4)

Fastest customizable press release news feed in the world

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights

Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference

Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

Live Leadership Updates

Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors

Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023

Shattuck Labs Announces Changes to its Board of Directors

Live finance-specific insights

Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway

Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Redmile Group, Llc sold $166,714 worth of shares (133,371 units at $1.25), bought $166,714 worth of shares (133,371 units at $1.25), disposed of $1,283,610 worth of shares (1,026,888 units at $1.25) and acquired $1,283,610 worth of shares (1,026,888 units at $1.25) (SEC Form 4)

Chief Executive Officer Schreiber Taylor bought $44,220 worth of shares (36,500 units at $1.21), increasing direct ownership by 106% to 71,002 units (SEC Form 4)

Director Brous Tyler bought $32,768 worth of shares (8,416 units at $3.89), increasing direct ownership by 4% to 238,088 units (SEC Form 4)

SEC Form 10-Q filed by Shattuck Labs Inc.

Shattuck Labs Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Amendment: SEC Form 10-K/A filed by Shattuck Labs Inc.

11/13/24 8:30:26 AM ET

$STTK

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $STTK alert in real time by email

SC 13G/A 1 d816256dsc13ga.htm SC 13G/A SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934

(Amendment No. 2)*

SHATTUCK LABS, INC.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

82024L103

(CUSIP Number)

September 30, 2024

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐

Rule 13d-1(b)

☒

Rule 13d-1(c)

☐

Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications:

Taylor H. Wilson, Esq.

Haynes and Boone, LLP

2801 N Harwood St, Suite 2300

Dallas, Texas 75201

(214) 651-5000

SCHEDULE 13G

CUSIP No. 82024L103

(1)	Includes 849 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the exercise of options to purchase Common Stock (the “*Options*”) of the Issuer.

(2)

Based upon (i) 47,727,269 shares of Common Stock outstanding as of July 17, 2024, as disclosed in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024, that was filed by the Issuer with the U.S. Securities and Exchange Commission (“SEC”) on August 1, 2024, and (ii) 849 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the exercise of Options.

SCHEDULE 13G

CUSIP No. 82024L103

(1)	Includes 65 shares of Common Stock that may be acquired by Prosight Fund within 60 days upon the exercise of Options.

(2)

Based upon (i) 47,727,269 shares of Common Stock outstanding as of July 17, 2024, as disclosed in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024, that was filed by the Issuer with the SEC on August 1, 2024, and (ii) 849 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the exercise of Options.

SCHEDULE 13G

CUSIP No. 82024L103

(1)	Includes 213 shares of Common Stock that may be acquired by Prosight Plus Fund within 60 days upon the exercise of Options.

(2)

Based upon (i) 47,727,269 shares of Common Stock outstanding as of July 17, 2024, as disclosed in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024, that was filed by the Issuer with the SEC on August 1, 2024, and (ii) 849 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the exercise of Options.

SCHEDULE 13G

CUSIP No. 82024L103

(1)	Includes 849 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the exercise of Options.

(2)

Based upon (i) 47,727,269 shares of Common Stock outstanding as of July 17, 2024, as disclosed in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024, that was filed by the Issuer with the SEC on August 1, 2024, and (ii) 849 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the exercise of Options.

SCHEDULE 13G

CUSIP No. 82024L103

(1)	Includes 849 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the exercise of Options.

(2)

Based upon (i) 47,727,269 shares of Common Stock outstanding as of July 17, 2024, as disclosed in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024, that was filed by the Issuer with the SEC on August 1, 2024, and (ii) 849 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the exercise of Options.

Item 1.

(a)

Name of Issuer:

Shattuck Labs, Inc. (the “Issuer”)

(b)

Address of Issuer’s Principal Executive Offices:

500 W. 5th Street, Suite 1200

Austin, TX 78701

Item 2.

(a)

Name of Person Filing:

This statement is jointly filed by and on behalf of each of Prosight Management, LP, a Delaware limited partnership (“Prosight Management”), Prosight Fund, LP, a Delaware limited partnership (“Prosight Fund”), Prosight Plus Fund, LP, a Delaware limited partnership (“Prosight Plus Fund”), Prosight Partners, LLC, a Delaware limited liability company (“Prosight Partners”), and W. Lawrence Hawkins (collectively referred to herein as “Reporting Persons”). Prosight Management is the general partner and investment manager of, and may be deemed to indirectly beneficially own securities owned by, Prosight Fund and Prosight Plus Fund. Prosight Management is a sub-advisor for certain separate managed accounts (collectively, the “Managed Accounts”) and may be deemed to indirectly beneficially own securities owned by the Managed Accounts. Prosight Partners is the general partner of, and may be deemed to beneficially own, securities beneficially owned by Prosight Management. Mr. Hawkins is the sole manager of, and may be deemed to beneficially own securities beneficially owned by, Prosight Partners. Prosight Fund, Prosight Plus Fund, and the Managed Accounts are the record and direct beneficial owner of the shares of Common Stock of the Issuer covered by this statement. Prosight Fund disclaims beneficial ownership of the shares of Common Stock of the Issuer held by each of the Managed Accounts, and Prosight Plus Fund. Prosight Plus Fund disclaims beneficial ownership of the shares of Common Stock of the Issuer held by each of the Managed Accounts, and Prosight Fund.

Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial owner of any securities covered by this statement.

Each Reporting Person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for the purpose of Section 13(d) or 13(g) of the Act. Each of the Reporting Persons declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purpose of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.

(b)

Address of Principal Business Office or, if None, Residence:

The address of the principal business office of each of the Reporting Persons is c/o Prosight Management, LP, 5956 Sherry Lane, Suite 1365, Dallas, Texas 75225.

(c)

Citizenship:

See Item 4 on the cover page(s) hereto.

(d)

Title and Class of Securities:

Common Stock, $0.0001 par value per share (“Common Stock”)

(e)

CUSIP No.:

82024L103

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:


(a)	☐	Broker or dealer registered under Section 15 of the Act;

(b)	☐	Bank as defined in Section 3(a)(6) of the Act;

(c)	☐	Insurance company as defined in Section 3(a)(19) of the Act;

(d)	☐	Investment company registered under Section 8 of the Investment Company Act of 1940;

(e)	☐	An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

(f)	☐	An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

(g)	☐	A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

(h)	☐	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)	☐	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

(j)	☐	A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);

(k)	☐	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

Item 4.

Ownership

(a)

Amount Beneficially Owned as of the time of filing: See Item 9 on the cover pages(s) hereto.

(b)

Percent of Class as of the time of filing: See Item 11 on the cover page(s) hereto.

(c)

As of the time of filing, number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: See Item 5 on the cover pages hereto.

(ii)

Shared power to vote or to direct the vote: See Item 6 on the cover pages hereto.

(iii)

Sole power to dispose or to direct the disposition of: See Item 7 on the cover pages hereto.

(iv)

Shared power to dispose or to direct the disposition of: See Item 8 on the cover pages hereto.

Item 5.

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owners of more than five percent of the class of securities, check the following [ ].

Item 6.

Ownership of more than Five Percent on Behalf of Another Person.

Not applicable

Item 7.

Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

Not applicable

Item 8.

Identification and classification of members of the group.

Not applicable

Item 9.

Notice of Dissolution of Group.

Not applicable

Item 10.

Certifications.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: November 13, 2024


PROSIGHT MANAGEMENT, LP

By:		Prosight Partners, LLC
Its:		General Partner

By:		/s/ W. Lawrence Hawkins
Name:		W. Lawrence Hawkins
Title:		Sole Manager

PROSIGHT FUND, LP

By:		Prosight Management, LP
Its:		General Partner

By:		Prosight Partners, LLC
Its:		General Partner

By:		/s/ W. Lawrence Hawkins
Name:		W. Lawrence Hawkins
Title:		Sole Manager

PROSIGHT PLUS FUND, LP

By:		Prosight Management, LP
Its:		General Partner

By:		Prosight Partners, LLC
Its:		General Partner

By:		/s/ W. Lawrence Hawkins
Name:		W. Lawrence Hawkins
Title:		Sole Manager

PROSIGHT PARTNERS, LLC

By:		/s/ W. Lawrence Hawkins
Name:		W. Lawrence Hawkins
Title:		Sole Manager

W. LAWRENCE HAWKINS

/s/ W. Lawrence Hawkins

EXHIBIT INDEX


Exhibit		Description of Exhibit

99.1		Joint Filing Agreement (incorporated herein by reference to Exhibit 99.1 to the Schedule 13G filed on December 29, 2023, by the Reporting Persons with the SEC).

Get the next $STTK alert in real time by email

Date	Price Target	Rating	Analyst
3/17/2025	$4.00	Outperform	Leerink Partners
10/2/2024	$8.00 → $2.00	Buy → Neutral	Citigroup
10/2/2024		Buy → Hold	Needham
10/1/2024		Buy → Neutral	H.C. Wainwright
6/17/2024		Buy → Neutral	BTIG Research
8/31/2022	$12.00	Buy	BTIG Research
6/1/2022	$13.00	Buy	Citigroup
5/2/2022	$28.00	Buy	H.C. Wainwright

Names of Reporting Persons

Prosight Management, LP

Check the appropriate box if a member of a Group (see instructions)

(a) ☐ (b) ☒

SEC Use Only

Citizenship or Place of Organization

Delaware